NCT01711554 2026-03-18
Lenalidomide and Dinutuximab With or Without Isotretinoin in Treating Younger Patients With Refractory or Recurrent Neuroblastoma
National Cancer Institute (NCI)
Phase 1 Active not recruiting
National Cancer Institute (NCI)
Belarusian Research Center for Pediatric Oncology, Hematology and Immunology